Save your place

Sign in to WhoBought

Please try again later.

Quince Therapeutics, Inc. (QNCX) institutional ownership

Market cap$90M SectorHealthcare
Funds holding · Q1 2026
6
reported QNCX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
6 buyers · 0 sellers

Quince Therapeutics, Inc. (QNCX) price and institutional activity

Dates

Q1 2026

$0 bought by 6 investors
Gen-Wealth Partners IncCatalyst Funds Management Pty Ltd +4 more
$0 sold by 0 investors
Bought Sold Totals per quarter; hover a bar for the names.

Quince Therapeutics, Inc. (QNCX) institutional activity · 6

Investor Type Est. change Change Δ Own Date
Gen-Wealth Partners Inc · New
Change +33K Date Q1 2026
Gen-Wealth Partners Inc New· Q1 2026 +33K Q1 2026
Catalyst Funds Management Pty Ltd · New
Change +30K Date Q1 2026
Catalyst Funds Management Pty Ltd New· Q1 2026 +30K Q1 2026
Fortitude Family Office, LLC · New
Change +8K Date Q1 2026
Fortitude Family Office, LLC New· Q1 2026 +8K Q1 2026
Advisory Services Network, LLC · New
Change +6K Date Q1 2026
Advisory Services Network, LLC New· Q1 2026 +6K Q1 2026
Parallel Advisors, LLC · New
Change +795 Date Q1 2026
Parallel Advisors, LLC New· Q1 2026 +795 Q1 2026
Sbi Securities Co., Ltd. · New
Change +135 Date Q1 2026
Sbi Securities Co., Ltd. New· Q1 2026 +135 Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
6 of 6

Quince Therapeutics, Inc. (QNCX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lamond David · Director Grant (A) 3K
Owned 3K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Lamond David Director Grant (A) 3K 3K Jun 11, 2026 Jun 15, 2026
Senner Christopher J. · Director Grant (A) 3K
Owned 3K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Senner Christopher J. Director Grant (A) 3K 3K Jun 11, 2026 Jun 15, 2026
Roberts Brigette · Director 9 operations 16.7M
Owned 6.8M Trade date May 18, 2026 Filed date Jun 11, 2026
Roberts Brigette Director 9 operations 16.7M 6.8M May 18, 2026 Jun 11, 2026
Thye Dirk · Director, Officer Grant (A) 1.0M
Owned 1.0M Trade date Jan 23, 2026 Filed date Jan 23, 2026
Thye Dirk Director, Officer Grant (A) 1.0M 1.0M Jan 23, 2026 Jan 23, 2026
Ryan Charles S. · Officer Grant (A) 200K
Owned 200K Trade date Jan 23, 2026 Filed date Jan 23, 2026
Ryan Charles S. Officer Grant (A) 200K 200K Jan 23, 2026 Jan 23, 2026
Hannah Brendan · Officer Grant (A) -365K
Owned 365K Trade date Jan 23, 2026 Filed date Jan 23, 2026
Hannah Brendan Officer Grant (A) -365K 365K Jan 23, 2026 Jan 23, 2026
Senner Christopher J. · Director Grant (A) 22K
Owned 22K Trade date Jan 2, 2026 Filed date Jan 21, 2026
Senner Christopher J. Director Grant (A) 22K 22K Jan 2, 2026 Jan 21, 2026
McLoughlin Margaret · Director Grant (A) 20K
Owned 20K Trade date Jan 2, 2026 Filed date Jan 21, 2026
McLoughlin Margaret Director Grant (A) 20K 20K Jan 2, 2026 Jan 21, 2026
Lamond David · Director Grant (A) 29K
Owned 29K Trade date Jan 2, 2026 Filed date Jan 21, 2026
Lamond David Director Grant (A) 29K 29K Jan 2, 2026 Jan 21, 2026
Bray June · Director Grant (A) 19K
Owned 19K Trade date Jan 2, 2026 Filed date Jan 21, 2026
Bray June Director Grant (A) 19K 19K Jan 2, 2026 Jan 21, 2026
Benatti Luca · Director Sell −$174K
Price $3.47 Qty −50K Owned 39K Trade date Dec 26, 2025 Filed date Dec 29, 2025
Benatti Luca Director Sell $3.47 −50K −$174K 39K Dec 26, 2025 Dec 29, 2025
Thye Dirk · Director, Officer 2 operations 0
Owned 740K Trade date Dec 10, 2025 Filed date Dec 12, 2025
Thye Dirk Director, Officer 2 operations 0 740K Dec 10, 2025 Dec 12, 2025
Hannah Brendan · Officer 4 operations 0
Price $0.55–$0.94 Owned 45K Trade date Dec 5, 2025 Filed date Dec 8, 2025
Hannah Brendan Officer 4 operations $0.55–$0.94 0 45K Dec 5, 2025 Dec 8, 2025
13 of 13

Quince Therapeutics, Inc. (QNCX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Group One Trading LLC 5.9M
% of shares outstanding 10.7% Filing date Mar 5, 2026
Group One Trading LLC 5.9M 10.7% Mar 5, 2026
Lamond David 4.5M
% of shares outstanding 10.1% Filing date Nov 13, 2024
Lamond David 4.5M 10.1% Nov 13, 2024
Tang Capital Partners LP 3.6M
% of shares outstanding 10.0% Filing date Mar 31, 2023
Tang Capital Partners LP 3.6M 10.0% Mar 31, 2023
Nantahala Capital Management, LLC 4.5M
% of shares outstanding 7.5% Filing date May 15, 2026
Nantahala Capital Management, LLC 4.5M 7.5% May 15, 2026
Integrated Core Strategies (us) LLC 1.4M
% of shares outstanding 7.2% Filing date Jun 10, 2026
Integrated Core Strategies (us) LLC 1.4M 7.2% Jun 10, 2026
Capital International Investors 1.5M
% of shares outstanding 4.9% Filing date Dec 10, 2021
Capital International Investors 1.5M 4.9% Dec 10, 2021
Sofinnova Capital VIII 1.2M
% of shares outstanding 2.7% Filing date Apr 30, 2025
Sofinnova Capital VIII 1.2M 2.7% Apr 30, 2025
Pfizer Inc 600K
% of shares outstanding 2.0% Filing date Feb 14, 2022
Pfizer Inc 600K 2.0% Feb 14, 2022
8 of 13

Quince Therapeutics, Inc. (QNCX) ownership FAQ

Who owns QNCX?

6 reporting institutions disclosed QNCX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.